The specific protocol used in any individual case depends on the patient's clinical picture and is determined by the provider
Cortico-Basal Ganglia reward network: microcircuitry
Semaglutide stimulates GLP-1 receptors to increase insulin secretion in response to meals, suppress glucagon, and slow gastric emptying, while tirzepatide adds GIP receptor action that further reduces appetite and body weight
Alberti L, Girola A, Gilardini L, et al
Chemotherapy-Induced Neuropathy Negative trial: A clinical study among people receiving platinum-based chemotherapy found that taking 600 mg of alpha-lipoic acid three times daily (1,800 mg total) for 24 weeks during chemotherapy did not reduce the incidence of chemotherapy-related nerve damage compared to placebo
Where to inject The best injection sites for GLP-1 medications include the abdomen (at least two inches from the navel), the front of the thighs, and the back of the upper arms